Keyphrases
Baboon
17%
Basal Ganglia
13%
Blinking
9%
Blood Flow
9%
Brain Structure
8%
Cerebral Blood Flow
6%
Chronic Tic Disorder
10%
D2 Receptor
17%
Deep Brain Stimulation
7%
Dopamine
20%
Dopamine Agonist
6%
Dopamine D2 Receptor (DRD2)
11%
Flow Response
8%
Focal Dystonia
6%
Functional Magnetic Resonance Imaging
15%
Functional Tics
8%
Hippocampal Volume
7%
Image Registration
6%
Levodopa
34%
Magnetic Resonance Imaging
8%
Movement Disorders
9%
Neuroimaging
17%
Nonhuman Primate
10%
Obesity
7%
Parkinson Patients
9%
Parkinson's Disease
47%
Parkinsonism
10%
Pathophysiology
11%
Pediatric
7%
Pharmacodynamics
8%
Pharmacological MRI (phMRI)
7%
Placebo
7%
Positron Emission Tomography
13%
Provisional Tic Disorder
12%
Psychosis
7%
Putamen
11%
Radioligand
7%
Randomized Placebo-controlled Trial
7%
Receptor Binding
12%
Regional Cerebral Blood Flow (rCBF)
17%
Specific Binding
7%
Striatal
11%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
9%
Template Image
7%
Tic Disorders
36%
Tic Severity
10%
Tic Suppression
19%
Tourette Syndrome
100%
Type 1 Diabetes Mellitus (T1DM)
7%
Type I Diabetes
7%
Neuroscience
Agonist
8%
Arterial Spin Labeling
5%
Basal Ganglia
13%
Behavior (Neuroscience)
10%
Body Mass Index
8%
Dementia Praecox
6%
DNA Template
7%
Dopamine Agonist
7%
Dopamine Receptor D2
8%
Dopaminergic
8%
Dystonia
11%
Eicosanoid Receptor
9%
Electrical Brain Stimulation
12%
Fluorine-18
6%
Frontal Lobe
5%
Functional Connectivity
6%
Functional Magnetic Resonance Imaging
19%
Gray Matter
5%
Hyperglycemia
6%
Hypoglycemia
6%
In Vivo
7%
L-DOPA
32%
Magnetic Resonance Imaging
12%
Magnetic Resonance Imaging
10%
Parkinson's Disease
52%
Parkinsonism
9%
Pimavanserin
5%
Placebo
12%
Positron Emission Tomography
17%
Positron Emission Tomography
10%
Putamen
11%
Radioligand
7%
Receptor Binding
12%
Stereotypic Movement Disorder
8%
Substantia nigra
5%
Subthalamic Nucleus
7%
Thalamus
9%
Tic Disorder
83%
Tourette Syndrome
62%
Typical Antipsychotic
6%